Methodology, Criteria, and Characterization of Patient-Matched Thyroid Cell Lines and Patient-Derived Tumor Xenografts

Por Marlow, Laura A, Rohl, Stephen D, Miller, James L, Knauf, Jeffery A, Fagin, James A, Ryder, Mabel, Milosevic, Dragana, Netzel, Brian C, Grebe, Stefan K, Reddi, Honey V, Smallridge, Robert C, Copland, John A
Publicado no J Clin Endocrinol Metab (2018)

Foxo3a drives proliferation in anaplastic thyroid carcinoma through transcriptional regulation of cyclin A1: a paradigm shift that impacts current therapeutic strategies

Por Marlow, Laura A., von Roemeling, Christina A., Cooper, Simon J., Zhang, Yilin, Rohl, Stephen D., Arora, Shilpi, Gonzales, Irma M., Azorsa, David O., Reddi, Honey V., Tun, Han W., Döppler, Heike R., Storz, Peter, Smallridge, Robert C., Copland, John A.
Publicado em 2012

Detailed Molecular Fingerprinting of Four New Anaplastic Thyroid Carcinoma Cell Lines and Their Use for Verification of RhoB as a Molecular Therapeutic Target

Por Marlow, Laura A., D'Innocenzi, Jaclyn, Zhang, Yilin, Rohl, Stephen D., Cooper, Simon J., Sebo, Thomas, Grant, Clive, McIver, Bryan, Kasperbauer, Jan L., Wadsworth, J. Trad, Casler, John D., Kennedy, Pamela W., Highsmith, W. Edward, Clark, Orlo, Milosevic, Dragana, Netzel, Brian, Cradic, Kendall, Arora, Shilpi, Beaudry, Christian, Grebe, Stefan K., Silverberg, Marc L., Azorsa, David O., Smallridge, Robert C., Copland, John A.
Publicado em 2010